Interestingly, in the setting of GVHD after donor T cells were transplanted, an increase in CD4+FoxP3+ Treg frequency was observed with Minnelide treatment in several GVHD target tissues (e.g., spleen, colon, and lung). Here, CD4 is linked to graft versus host disease.